PACB - Pacific Biosciences of California GAAP EPS of -$0.37 misses by $0.05 revenue of $33.17M beats by $0.35M May, 04 2022 04:06 PM Pacific Biosciences of California Inc. Pacific Biosciences of California press release (NASDAQ:PACB): Q1 GAAP EPS of -$0.37 misses by $0.05. Revenue of $33.17M (+14.4% Y/Y) beats by $0.35M. For further details see: Pacific Biosciences of California GAAP EPS of -$0.37 misses by $0.05, revenue of $33.17M beats by $0.35M